[
  {
    "ts": null,
    "headline": "AMGN Q1 Earnings Call: Product Pipeline and Margin Expansion Drive Outperformance",
    "summary": "Biotech company Amgen (NASDAQ:AMGN) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 9.4% year on year to $8.15 billion. The company expects the full year’s revenue to be around $35 billion, close to analysts’ estimates. Its non-GAAP profit of $4.90 per share was 15% above analysts’ consensus estimates.",
    "url": "https://finnhub.io/api/news?id=631c14303684b18797e5fda02b9373a88bdf29a617e2c990b2296c797cfb478c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747341723,
      "headline": "AMGN Q1 Earnings Call: Product Pipeline and Margin Expansion Drive Outperformance",
      "id": 134498742,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Biotech company Amgen (NASDAQ:AMGN) reported Q1 CY2025 results topping the market’s revenue expectations, with sales up 9.4% year on year to $8.15 billion. The company expects the full year’s revenue to be around $35 billion, close to analysts’ estimates. Its non-GAAP profit of $4.90 per share was 15% above analysts’ consensus estimates.",
      "url": "https://finnhub.io/api/news?id=631c14303684b18797e5fda02b9373a88bdf29a617e2c990b2296c797cfb478c"
    }
  },
  {
    "ts": null,
    "headline": "Amgen owes $406 million for monopolizing cholesterol drug market, US jury says",
    "summary": "A federal jury in Delaware said onThursday that biotech company Amgen owes competitorRegeneron more than $406 million for engaging inanticompetitive behavior to increase sales of...",
    "url": "https://finnhub.io/api/news?id=f9d53c4355e36b9841f50c0707b77893fa0f86c0c68bf0681870b46a3803bca7",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747328060,
      "headline": "Amgen owes $406 million for monopolizing cholesterol drug market, US jury says",
      "id": 134485216,
      "image": "",
      "related": "AMGN",
      "source": "Finnhub",
      "summary": "A federal jury in Delaware said onThursday that biotech company Amgen owes competitorRegeneron more than $406 million for engaging inanticompetitive behavior to increase sales of...",
      "url": "https://finnhub.io/api/news?id=f9d53c4355e36b9841f50c0707b77893fa0f86c0c68bf0681870b46a3803bca7"
    }
  },
  {
    "ts": null,
    "headline": "Regeneron Gets $407 Million in Damages From Amgen in Antitrust Drug Lawsuit",
    "summary": "By Katherine Hamilton Regeneron Pharmaceuticals won $406.8 million in damages for a lawsuit claiming Amgen violated antitrust and tort laws. A jury in a Delaware court found that Amgen...",
    "url": "https://finnhub.io/api/news?id=1ea3271eb286609f46100a1901939809a3c450b60d964b43d5636c885a3b7c8c",
    "source": "Finnhub",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747323247,
      "headline": "Regeneron Gets $407 Million in Damages From Amgen in Antitrust Drug Lawsuit",
      "id": 134483873,
      "image": "",
      "related": "AMGN",
      "source": "Finnhub",
      "summary": "By Katherine Hamilton Regeneron Pharmaceuticals won $406.8 million in damages for a lawsuit claiming Amgen violated antitrust and tort laws. A jury in a Delaware court found that Amgen...",
      "url": "https://finnhub.io/api/news?id=1ea3271eb286609f46100a1901939809a3c450b60d964b43d5636c885a3b7c8c"
    }
  },
  {
    "ts": null,
    "headline": "Regeneron Gets $407M in Damages From Amgen in Antitrust Drug Lawsuit",
    "summary": "Regeneron Gets $407M in Damages From Amgen in Antitrust Drug Lawsuit",
    "url": "https://finnhub.io/api/news?id=fd1e66a44736b6d6f50983fe7f503a148cf2f8126ff69b21e676d5a2bc30f316",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747322280,
      "headline": "Regeneron Gets $407M in Damages From Amgen in Antitrust Drug Lawsuit",
      "id": 134489565,
      "image": "",
      "related": "AMGN",
      "source": "MarketWatch",
      "summary": "Regeneron Gets $407M in Damages From Amgen in Antitrust Drug Lawsuit",
      "url": "https://finnhub.io/api/news?id=fd1e66a44736b6d6f50983fe7f503a148cf2f8126ff69b21e676d5a2bc30f316"
    }
  },
  {
    "ts": null,
    "headline": "Cisco, Amgen share gains lead Dow's nearly 225-point jump",
    "summary": "Cisco, Amgen share gains lead Dow's nearly 225-point jump",
    "url": "https://finnhub.io/api/news?id=10d2119d74a9d244bdd3970e8c57e0d41c5f2ee21d98c3d2899c95b97fddbef5",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747314240,
      "headline": "Cisco, Amgen share gains lead Dow's nearly 225-point jump",
      "id": 134487864,
      "image": "",
      "related": "AMGN",
      "source": "MarketWatch",
      "summary": "Cisco, Amgen share gains lead Dow's nearly 225-point jump",
      "url": "https://finnhub.io/api/news?id=10d2119d74a9d244bdd3970e8c57e0d41c5f2ee21d98c3d2899c95b97fddbef5"
    }
  },
  {
    "ts": null,
    "headline": "Cisco, Verizon share gains contribute to Dow's 115-point jump",
    "summary": "Cisco, Verizon share gains contribute to Dow's 115-point jump",
    "url": "https://finnhub.io/api/news?id=1d937a8c3d03f51055102bc808e76ff1a9032267fa8641e3d5b337b6f605a49c",
    "source": "MarketWatch",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1747308120,
      "headline": "Cisco, Verizon share gains contribute to Dow's 115-point jump",
      "id": 134474606,
      "image": "",
      "related": "AMGN",
      "source": "MarketWatch",
      "summary": "Cisco, Verizon share gains contribute to Dow's 115-point jump",
      "url": "https://finnhub.io/api/news?id=1d937a8c3d03f51055102bc808e76ff1a9032267fa8641e3d5b337b6f605a49c"
    }
  }
]